MedTrace Logo

Switching From Usual Brand Cigarettes to a Tobacco-heating Cigarette or Snus

NCT02061917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2016-02-17

No results posted yet for this study

Summary

To evaluate selected biomarkers of tobacco exposure and biomarkers of harm and assess quality of life measures in smokers randomly switched from their usual brand of cigarette to one of three test products: (1) a tobacco-heating cigarette; (2) snus (smokeless tobacco); or (3) an ultra-low machine yield tobacco-burning cigarette.

Conditions

  • Cigarette Smoking

Interventions

OTHER

Tobacco-Heating Cigarette

Smokers switched to a tobacco-heating cigarette for 24 weeks

OTHER

Snus (Smokeless Tobacco)

Smokers switched to snus product for 24 weeks

OTHER

Tobacco-Burning Cigarette

Smokers switched to a tobacco-burning cigarette for 24 weeks

Sponsors & Collaborators

  • Analytisch-biologisches Forschungslabor GmbH

    collaborator INDUSTRY

  • Arista Laboratories

    collaborator UNKNOWN

  • Covance

    collaborator INDUSTRY

  • Covance IVRS

    collaborator UNKNOWN

  • Pacific Biomarkers

    collaborator OTHER

  • University of Louisville

    collaborator OTHER

  • R.J. Reynolds Tobacco Company

    lead INDUSTRY

Principal Investigators

  • Michael W Ogden, Ph.D. · R.J. Reynolds Tobacco Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
28 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2007-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02061917 on ClinicalTrials.gov